Flecainide in Treating Patients With Chronic Neuropathic Pain

Completed · Phase 2

Conditions studied: Pain

In brief

RATIONALE: Flecainide therapy may help patients with neuropathic pain live more comfortably. PURPOSE: Phase II trial to study the effectiveness of flecainide in treating patients with chronic neuropathic pain from cancer or AIDS.

Key facts

Study ID

NCT00002996

Run by

Eastern Cooperative Oncology Group

People needed

20

Starts

1998-05-04

Last updated by the study team

2023-06-15

Who can join

Age: 19 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CCOP - Cedar Rapids Oncology Project — Cedar Rapids, Iowa, United States
• CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
• CCOP - Kalamazoo — Kalamazoo, Michigan, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.